A venture-backed European biotechnology company in the respiratory disease space had just cl...
A venture-backed European biotechnology company in the respiratory disease space had just cl...
Clinical trials don't pause for difficult days. Neither do the people running them.The site ...
Barrington James partnered with an established biopharmaceutical client to deliver a Clinica...
A global biotech company specialising in Immunology and Inflammation was approaching a criti...
From pipeline to patients: oncology launches to watchFiercePharma’s recent report on t...
January’s JP Morgan Healthcare Conference set the tone for the year ahead, and whi...
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...
Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...